ESC Premium Access

Assessment of clinical risk factors for all-cause mortality among hypertrophic cardiomyopathy patients with ICDs.

Congress Presentation

About the speaker

Mr Szymon Mielczarek

Institute of Cardiology in Anin, Warsaw (Poland)
0 follower

9 more presentations in this session

Future risk of bradyarrhythmias in patients with hypertrophic cardiomyopathy and implantable cardioverter defibrillator indication

Speaker: Doctor K. Nakasuka (San Francisco, US)


Dilated cardiomyopathy - a group that does not benefit from ICD?

Speaker: Doctor P. Silverio Antonio (Lisbon, PT)


Implantable cardioverter defibrillators in patients with electrical heart disease and hypertrophic cardiomyopathy - data from the German device Registry

Speaker: Professor G. Frommeyer (Munster, DE)


Incidence of appropriate implantable cardioverter defibrillator therapy and sudden cardiac death in cardiac sarcoidosis - a systematic review and meta-analysis

Speaker: Mr K. Franke (Adelaide, AU)


Predicting arrhythmic risk in dilated cardiomyopathy: a systematic review & meta-analysis of clinical parameters

Speaker: Doctor A. Sammani (Utrecht, NL)


Access the full session

Poster Session 1 - Arrhythmia in cardiomyopathy

Speakers: Mr S. Mielczarek, Doctor K. Nakasuka, Doctor P. Silverio Antonio, Professor G. Frommeyer, Mr K. Franke...

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb